Department of Psychiatry, Icahn School of Medicine At Mount Sinai, Gustave L. Levy Place, Box 1230, New York, NY, 10029, USA.
Department of Neuroscience, Icahn School of Medicine At Mount Sinai, Gustave L. Levy Place, Box 1230, New York, NY, 10029, USA.
Psychopharmacology (Berl). 2022 Apr;239(4):1019-1033. doi: 10.1007/s00213-021-05868-x. Epub 2021 Jun 5.
Emotion recognition is impaired in drug addiction. However, research examining the effects of cocaine use on emotion recognition yield mixed evidence with contradictory results potentially reflecting varying abstinence durations.
Therefore, we investigated emotion recognition and its neural correlates in individuals with cocaine use disorder (CUD) parsed according to abstinence duration.
Emotion recognition performance was compared between current cocaine users (CUD + , n = 28; cocaine-positive urine), short-term abstainers (CUD-ST, n = 23; abstinence < 6 months), long-term abstainers (CUD-LT, n = 20; abstinence ≥ 6 months), and controls (n = 45). A sample subset (n = 73) underwent structural magnetic resonance imaging to quantify regional gray matter volume (GMV) using voxel-based morphometry.
CUD + demonstrated greater difficulty recognizing happiness than CUD-ST and controls, and sadness and fear compared to controls (p < 0.01). For fear, CUD-ST also performed worse than controls (p < 0.01), while no differences emerged between CUD-LT and controls. Whole-brain analysis revealed lower GMV in the bilateral cerebellum in CUD + compared to CUD-LT and controls; a similar pattern was observed in the amygdala (CUD + < CUD-LT) (p < 0.01). Collapsed across all participants, poorer recognition for happiness was associated with lower right cerebellar GMV (p < 0.05).
Emotion recognition is impaired with current cocaine use, and selective deficits (in fear) may persist with up to 6 months of abstinence. Lower cerebellar GMV may underlie deficits in positive emotion recognition. Interventions targeting emotional-social-cognitive deficits, especially among active users, may enhance treatment success for individuals with CUD.
情绪识别在药物成瘾中受损。然而,研究可卡因使用对情绪识别的影响产生了混合的证据,结果相互矛盾,这可能反映了不同的禁欲持续时间。
因此,我们根据禁欲时间对可卡因使用障碍(CUD)患者的情绪识别及其神经相关性进行了研究。
比较了当前可卡因使用者(CUD+,n=28;可卡因阳性尿液)、短期禁欲者(CUD-ST,n=23;禁欲<6 个月)、长期禁欲者(CUD-LT,n=20;禁欲≥6 个月)和对照组(n=45)的情绪识别表现。一个样本子集(n=73)接受了结构磁共振成像,使用基于体素的形态测量学来量化区域灰质体积(GMV)。
CUD+在识别快乐方面比 CUD-ST 和对照组更困难,在识别悲伤和恐惧方面比对照组更困难(p<0.01)。对于恐惧,CUD-ST 也比对照组表现更差(p<0.01),而 CUD-LT 与对照组之间没有差异。全脑分析显示,与 CUD-LT 和对照组相比,CUD+双侧小脑的 GMV 较低;在杏仁核中也观察到类似的模式(CUD+<CUD-LT)(p<0.01)。在所有参与者中,对幸福的识别较差与右侧小脑 GMV 较低相关(p<0.05)。
当前可卡因使用会导致情绪识别受损,而长达 6 个月的禁欲可能会导致选择性缺陷(恐惧)持续存在。较低的小脑 GMV 可能是积极情绪识别缺陷的基础。针对情感-社会-认知缺陷的干预措施,尤其是针对活跃使用者的干预措施,可能会提高可卡因使用障碍患者的治疗成功率。